Choice of first line migraine medication shows wide variation

The wide heterogeneity in the use of first line treatment for migraine across headache centres globally shows the need for better evidence to inform guidance, researchers say. A study of 600 patients from seven countries including Australia found the most commonly used acute drugs were triptans (70.3%) especially sumatriptan, followed by NSAIDs (63.3%). Triptans were ...

Already a member?

Login to keep reading.

© 2022 the limbic